AFP is involved in multidrug resistance (MDR) by activating the PI3K/AKT/mTOR signalling pathway, which leads to metabolic reprogramming of cancer stem cells, inhibition of the expression of apoptosis‐related enzymes and resistance to tumour cell apoptosis.13, 14, 15. This evidence concerns the gene AFP and neoplasm.